Interactions of phytic acid with anticancer drug targets Online publication date: Tue, 07-Mar-2017
by Amitha Joy; S. Balaji
International Journal of Computational Biology and Drug Design (IJCBDD), Vol. 10, No. 1, 2017
Abstract: Inositol hexakisphosphate is known to be the phosphorous reserve in plants particularly in the seeds. Although it has been known for its anti-nutrient properties for many years, recent research shed light on its anticancer properties. Hence, the present study focuses on probable protein targets of phytic acid (PA) through computational methods. Anticancer targets of Regorafenib (23 targets) along with two more protein targets such as mitogen-activated kinase and inositol 1,4,5-trisphosphate receptor were included in the study. Docking studies were performed with PA along with regorafenib (as a reference inhibitor) for the selected targets and sorted out the best conformations based on minimum free energy of binding. The best rank was obtained for inositol 1,4,5-trisphosphate receptor (−5.02 Kcal/mol) and the least scored one was discoidin domain-containing receptor 2 (−1.56 Kcal/mol). The binding site interactions and affinities of PA were computed and presented.
Online publication date: Tue, 07-Mar-2017
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Computational Biology and Drug Design (IJCBDD):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email email@example.com